logo

Immunogen Inc (IMGN)



Trade IMGN now with
  Date
  Headline
8/29/2017 6:34:46 AM Jazz Pharma, ImmunoGen Announce Strategic Collaboration And Option Agreement To Commercialize ADC Products
7/28/2017 6:35:13 AM ImmunoGen Q2 Net Loss $8.9 Mln Or $0.10 Per Share
7/6/2017 6:28:16 AM RBC Capital Markets Is Cutting Immunogen Inc (IMGN) 2019 Estimate To -1.78 From -1.69
7/6/2017 6:27:56 AM RBC Capital Markets Is Cutting Immunogen Inc (IMGN) 2018 Estimate To -1.81 From -1.63
7/6/2017 6:27:17 AM RBC Capital Markets Is Increasing Immunogen Inc (IMGN) 2017 Estimate To -0.80 From -1.37
7/6/2017 6:26:55 AM RBC Capital Markets Is Increasing Immunogen Inc (IMGN) Q4 18 Estimate To -0.42 From -0.45
7/6/2017 6:26:37 AM RBC Capital Markets Is Cutting Immunogen Inc (IMGN) Q3 18 Estimate To -0.48 From -0.42
7/6/2017 6:26:20 AM RBC Capital Markets Is Lowering Immunogen Inc (IMGN) Q2 18 Estimate To -0.45 From -0.43
7/6/2017 6:26:08 AM RBC Capital Markets Is Cutting Immunogen Inc (IMGN) Q1 18 Estimate To -0.46 From -0.34
7/6/2017 6:25:53 AM RBC Capital Markets Is Increasing Immunogen Inc (IMGN) Q4 17 Estimate To 0.39 From -0.37
7/6/2017 6:25:37 AM RBC Capital Markets Is Increasing Immunogen Inc (IMGN) Q3 17 Estimate To 0.42 From -0.40
7/6/2017 6:25:18 AM RBC Capital Markets Is Increasing Immunogen Inc (IMGN) Q2 17 Estimate To 0.18 From -0.39
7/6/2017 6:09:29 AM RBC Capital Markets Lifts Immunogen Inc (IMGN) To Outperform From Sector Perform With $12 Up From $5 Price Target